First LSA instrument sales are to a broad range of initial customers, including large pharmaceutical, biotech, CRO and academic institutions. Salt Lake City, Utah. Carterra Inc., an innovative label-free biosensor company, announced today that it has sold multiple units of its new, fully integrated, high throughput monoclonal antibody (mAb) screening and characterization instrument, the LSA™. Initial […]
Highlights: Acquisition advances Agilent’s growth strategy. Highly attractive business with robust growth track record and prospects. Combination strengthens customer value proposition with complementary technologies and solutions. Opportunity to accelerate expansion into adjacent businesses. SANTA CLARA, Calif. Agilent Technologies, Inc. (NYSE: A) today announced that it has signed a definitive agreement to acquire privately-held Advanced Analytical Technologies, Inc. (AATI), a provider of capillary electrophoresis-based (CE) […]
TGR BioSciences is proud to announce the global availability of Alpha Terbium SureFire® Ultra™ (TBSU) assay kits. These new kits can be easily combined with existing AlphaLISA® SureFire Ultra (ALSU) kits to provide high throughput capability of multiplexed phosphoprotein detection in a homogeneous assay format. The new kits combine PerkinElmer, Inc.’s highly sensitive and homogeneous Alpha (Amplified Luminescent Proximity Homogenous […]
Heidelberg, Germany and Cambridge, UK – SYGNIS AG (Frankfurt: LIO1; ISIN: DE000A1RFM03; Prime Standard), today announced its subsidiaries Innova Biosciences, Expedeon Holdings, and C.B.S. Scientific have united as Expedeon, effective 1 March 2018. The corporate rebranding follows the latest acquisition of Innova Biosciences by SYGNIS AG in June 2017. SYGNIS AG will continue to serve as […]
Industry and academia to share expertise in effort to develop improved methods to produce and characterize antibodies and reagents for neurological research The Montreal Neurological Institute (The Neuro) of McGill University, a world-leading institution focused on brain research and advanced patient care, and Thermo Fisher Scientific, the world leader in serving science, today announce an […]
Investment will grow company’s expert team, accelerate development and commercialization of gene-editing tools — including enzymes, reagents, instrumentation, and software Boulder, Colo. – Inscripta, a leading gene-editing technology company, today announced that it has closed a $55.5 million Series C funding round led by Mérieux Développement and Paladin Capital Group. Additional participants include all existing Inscripta […]
AMSBIO is a specialist life science company offering an extensive portfolio of Poly (ADP-ribose) polymerase (PARP) isozymes. In addition, AMSBIO also offer assay kits, inhibitors, recombinant histone substrates and screening / profiling services for over 10 different PARP’s. Poly (ADP-ribose) polymerase (PARP) is a family of proteins that transfer ADP-ribose units from NAD+ onto target […]
ATUM licenses Company’s Leap-In Transposase® Technology to Just NEWARK, Calif.–Dedicated to creating technologies and tools to improve peoples’ lives, ATUM today announced a patent licensing agreement giving Just Biotherapeutics access to the company’s Leap-In cell line development tools. “We love everything about Just’s mission, and we are delighted that our Leap-In technology will be used to help democratize access […]
Fleet to provide support for Gyrolab platform users in developing, transferring and optimizing assays Uppsala, Sweden, and Hampshire, UK: Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers and reagents, and Fleet Bioprocessing Ltd. (Fleet), an expert provider of contract immunoassay development services and immunoassay reagent manufacture, announced today […]
InDevR has announced that it has expanded its VaxArray® product portfolio with a new reagent kit to address the “need for speed” in combating flu viruses with pandemic potential. The VaxArray Influenza Pandemic Hemagglutinin potency test kit is now available for flu vaccines containing H5, H7, and H9 flu subtypes, which includes new H7 vaccines against […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
